Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276120 · ClinicalTrials.gov registry record
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 4,385
- Enrollment target
NCT00276120 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 4,385 participants.
The verdict
NCT00276120 has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 4,385 participants
- Enrollment target
Study Summary
The purpose of this study is to identify novel genetic factors which distinguish breast cancer in younger women compared to older women. By identifying these novel genetic factors we believe more specific therapies can be developed and breast cancer may be prevented among women with an increased cancer risk. A woman does not have to live in St. Louis to participate.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,385 participants |
| Start Date | 2005-03 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276120
The ClinicalTrials.gov registry entry for NCT00276120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00276120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276120 about?
NCT00276120 is a clinical study titled "Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer". The purpose of this study is to identify novel genetic factors which distinguish breast cancer in younger women compared to older women. By identifying these novel genetic factors we believe more specific therapies can be developed and breast cancer may be prevented among women with an increased can...
What is the current status of trial NCT00276120?
This trial is currently completed. The enrollment target is 4,385 participants. The study started on 2005-03. Estimated completion is 2021-12-31.
Who is sponsoring clinical trial NCT00276120?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.